[Corrigendum] Next‑generation sequencing analysis reveals that MTH‑3, a novel curcuminoid derivative, suppresses the invasion of MDA‑MB‑231 triple‑negative breast adenocarcinoma cells.
Saved in:
| Title: | [Corrigendum] Next‑generation sequencing analysis reveals that MTH‑3, a novel curcuminoid derivative, suppresses the invasion of MDA‑MB‑231 triple‑negative breast adenocarcinoma cells. |
|---|---|
| Authors: | Chiu YJ; Division of Plastic and Reconstructive Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei 11217, Taiwan, R.O.C., Tsai FJ; Human Genetic Center, China Medical University, Taichung 40402, Taiwan, R.O.C., Bau DT; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan, R.O.C., Chang LC; Chinese Medicinal Research and Development Center, China Medical University Hospital, Taichung 40402, Taiwan, R.O.C., Hsieh MT; Chinese Medicinal Research and Development Center, China Medical University Hospital, Taichung 40402, Taiwan, R.O.C., Lu CC; Department of Sport Performance, National Taiwan University of Sport, Taichung 40402, Taiwan, R.O.C., Kuo SC; Chinese Medicinal Research and Development Center, China Medical University Hospital, Taichung 40402, Taiwan, R.O.C., Yang JS; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan, R.O.C. |
| Source: | Oncology reports [Oncol Rep] 2024 Jul; Vol. 52 (1). Date of Electronic Publication: 2024 Jun 07. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9422756 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2431 (Electronic) Linking ISSN: 1021335X NLM ISO Abbreviation: Oncol Rep Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
